Prostate specific antigen: a new means as diagnostic and prognostic factor for breast cancer

ABSTRACT Prostate specific antigen (PSA) is a serine protease expressed at high levels in prostate epithelium and elevated PSA in serum is a well established marker, and also helps in management of prostate cancer. In recent times it has become widely accepted that PSA is also present in many non prostatic sources, creating doubts about the specificity of its tissue expression. Numerous studies have suggested that the molecular forms of PSA imply to signify a potential tool for the risk assessment of breast cancer. Studies have suggested new biological role of PSA in breast physiopathology. Additional studies are essential to enrol PSA indisputably as an additional means as diagnostic and prognostic tool for breast cancer. Here is the summary of how PSA has a potential to become a new diagnostic and prognostic tool